SOPHIA ANTIPOLIS, FRANCE and MADISON, NJ--(Marketwire - Jan 29, 2013) - Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate Licensed from Nicox Bausch + Lomb, the global eye health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback